Overview

Luspatercept in Metastatic AGCT of the Ovary

Status:
COMPLETED
Trial end date:
2022-08-29
Target enrollment:
Participant gender:
Summary
This is a single participant study of luspatercept for the treatment of a patient with dult granulosa cell tumor (AGCT) of the ovary.
Phase:
NA
Details
Lead Sponsor:
University Health Network, Toronto
Treatments:
luspatercept